Free Republic
Browse · Search
Topics · Post Article

Skip to comments.

Drug approved to combat elderly blindness
Seattle Post-Intelligencer ^ | June 30, 2006 | ANDREW BRIDGES

Posted on 06/30/2006 8:56:45 PM PDT by neverdem


WASHINGTON -- The first drug shown to significantly improve the vision of patients threatened by a major cause of blindness in the elderly won federal approval Friday.

The drug, called Lucentis, treats the wet form of age-related macular degeneration, a disorder where blood vessels behind the retina leak blood and fluid, worsening vision and often causing blindness. An estimated 90 percent of the 1.4 million Americans who have lost their eyesight due to the disorder have the wet form.

Lucentis, made by Genentech, Inc., a South San Francisco, Calif., biotechnology company, inhibits the growth of blood vessels when injected into the eye. Other Food and Drug Administration-approved treatments can arrest progression of the disease, which can lead to blindness in just weeks or months, but none has been shown to significantly reverse deteriorating vision.

Genentech may find Lucentis competing against another of its drugs, the cancer treatment Avastin. Avastin is increasingly used to treat macular degeneration for as little as $17 a dose. Lucentis will cost $1,950 per injection, or more than 100 times as much. Each drug is typically injected monthly or bimonthly.

Lucentis and Avastin both block the same protein believed responsible for the blood vessel growth. Early results from Lucentis trials led doctors more than two years ago to begin experimenting with Avastin to treat age-related macular degeneration, commonly called AMD.

"It gave physicians and patients great hope we are going to be able to improve vision in our patients rather than just slow down the loss of vision," Dr. George Williams, an American Academy of Ophthalmology spokesman, said of the early results.

Since then, at least 10,000 macular degeneration patients have received Avastin injections, a so-called "off-label" use of the drug.

"It's become a worldwide phenomenon," said Dr. Philip Rosenfeld, a professor of ophthalmology at the Bascom Palmer Eye Institute in Miami, who pioneered its use for AMD.

The FDA does not sanction using Avastin to treat macular degeneration. Genentech stresses that it has not studied the safety or effectiveness of Avastin in treating the disease, nor does it plan to do so.

"We believe Lucentis is a much better choice," said Dr. Hal Barron, Genentech's chief medical officer. "I really believe when treating patients, you have to look at the wealth of data supporting its use and the quality of that data."

The National Eye Institute, part of the National Institutes of Health, has received an outside proposal to conduct a study comparing Avastin and Lucentis in treating AMD, said the government institute's Dr. Maryann Redford.

Genentech engineered Lucentis to better penetrate the retina while reducing inflammation, Barron said. Lucentis also clears the body faster than Avastin, and better targets the protein important to vessel formation, he added.

Still, the anticipated cost of Lucentis may constrain its use, since Avastin is far cheaper when vials of the cancer drug are divvied up and used to treat macular degeneration.

"The bottom line is, wherever price does matter, Avastin will probably be used as first-line therapy. But wherever price is not an issue, like in Medicare patients and Medicaid patients, Lucentis will be used," Rosenfeld said.

Neither drug is a cure for age-related macular degeneration. Lucentis is most effective when injected monthly, said Dr. Wiley Chambers, deputy director of the FDA's Division of Anti-infective and Opthalmologic Products. The disease is named for the macula, the central portion of the retina responsible for detailed central vision.

The two other FDA-approved therapies to treat macular degeneration are Novartis AG/QLT Inc.'s Visudyne, which combines a light-sensitive drug and laser therapy to seal leaking blood vessels, and OSI Pharmaceuticals Inc./Pfizer Inc.'s Macugen, which is injected into the eye. Both slow the progression of the disorder but typically reverse its effects in only 5 percent to 10 percent of patients, Chambers said.

Lucentis' most commonly reported side effects include conjunctival hemorrhage, eye pain, floaters, increased eye pressure and inflammation.

In clinical trials, nearly 95 percent of participants given monthly injections maintained their vision at one year, compared with the approximately 60 percent who did after receiving another treatment, the FDA said. Approximately one-third of the Lucentis patients also reported improved vision after a year.

Genentech said it would start shipping Lucentis on Friday.

On the Net:

Food and Drug Administration:

Genentech Inc.:

TOPICS: Business/Economy; Culture/Society; Extended News; Government; News/Current Events; US: California; US: District of Columbia; US: Maryland
KEYWORDS: amd; avastin; blindness; glaucoma; health; lucentis; macular; maculardegeneration; medicine; vegfinhibitor; wetamd
IIRC, someone asked what happened to the drugs that inhibited the blood supply in solid tumor experiments in rats a decade ago. I believe these drugs are it, and they inhibit vascular endothelial growth factor.
1 posted on 06/30/2006 8:56:47 PM PDT by neverdem
[ Post Reply | Private Reply | View Replies]

Comment #2 Removed by Moderator

To: neverdem
My almost 86 y/o, legally blind, Mom has been having this treatment for about 12 months. Initially she was hesitant because she was in a test group but she has gone from not being able to see any reading material to being able to read large print books. Prior to this intervention she was only able to read the great big E at the top of the eye chart, now she is reading three rows down. The change in her and her life has been remarkable.
3 posted on 06/30/2006 9:13:03 PM PDT by Tarheel (Good fences make good neighbors--R. Frost)
[ Post Reply | Private Reply | To 1 | View Replies]

To: Tarheel

Good for her!!!
Wish they had had this for my Mom. She went through that procedure where they inject a gas bubble and had her keep her face down for weeks. A lot of nothing is what she got from that.

4 posted on 06/30/2006 9:44:52 PM PDT by Roccus
[ Post Reply | Private Reply | To 3 | View Replies]

To: Tarheel
Get your mom's doctor to give her a shot of Avastin.

I don't know if a British paper can be posted here so this is the teaser and a link.

Better results for 1 (one) percent of the cost of Lucentis. Read the article ... really shows where the drug companies hearts are... if they had one.

"A major drug company is blocking access to a medicine that is cheaply and effectively saving thousands of people from going blind because it wants to launch a more expensive product on the market.

Ophthalmologists around the world, on their own initiative, are injecting tiny quantities of a colon cancer drug called Avastin into the eyes of patients with wet macular degeneration, a common condition of older age that can lead to severely impaired eyesight and blindness. They report remarkable success at very low cost because one phial can be split and used for dozens of patients." article

5 posted on 06/30/2006 9:51:30 PM PDT by Ron/GA
[ Post Reply | Private Reply | To 3 | View Replies]

To: El Gato; Ernest_at_the_Beach; Robert A. Cook, PE; lepton; LadyDoc; jb6; tiamat; PGalt; Dianna; ...
Common heart drugs might be bird flu weapon

Killer tomatoes attack human diseases

ANU [Australian National University] scientists crack DNA replication mystery

Let's Move Medicine Into the Information Age This comment was about one of the more satisfying disgnoses I helped to make, but it also shows how complete electronic medical records can help when patients can't give their medical history. I tried to write in plain English, not in medicalese.

FReepmail me if you want on or off my health and science ping list.

6 posted on 06/30/2006 10:18:39 PM PDT by neverdem (May you be in heaven a half hour before the devil knows that you're dead.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem


Will get this off to my dad ASAP. He's afflicted with the dread disease. Tends to have to leave his fun Caddy Escalade parked nowadays unless his step-daughter drives him in it.

7 posted on 06/30/2006 10:21:56 PM PDT by Quix (PRAY AND WORK WHILE THERE'S DAY! Many very dark nights are looming. Thankfully, God is still God!)
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem
"But wherever price is not an issue, like in Medicare patients and Medicaid patients, Lucentis will be used," Rosenfeld said.

That says a lot about why health care costs are going up so fast in this country.

I had an elderly friend with macular degeneration. He loved to read. For a while he was able to use special magnifying devices but eventually even these couldn't help him.

8 posted on 06/30/2006 10:26:11 PM PDT by wideminded
[ Post Reply | Private Reply | To 1 | View Replies]

To: kalee

for later reading

9 posted on 06/30/2006 11:21:47 PM PDT by kalee
[ Post Reply | Private Reply | To 5 | View Replies]

To: Tarheel

My tarheel dad is getting this treatment in Asheville and it appears to have stopped the degeneration and perhaps is even reversing some of it.

10 posted on 07/01/2006 3:42:11 AM PDT by xzins (Retired Army Chaplain and Proud of It. Supporting our Troops Means Praying for them to Win!)
[ Post Reply | Private Reply | To 3 | View Replies]

To: neverdem

Avastin injection brought back 80-85% of my left eye's vision. A miracle drug IMO.

11 posted on 07/01/2006 7:58:24 AM PDT by afnamvet (It is what it is.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: neverdem


12 posted on 07/01/2006 8:51:53 AM PDT by good old days
[ Post Reply | Private Reply | To 1 | View Replies]


13 posted on 07/01/2006 7:15:32 PM PDT by Museum Twenty (Proudly supporting President George W. Bush - Proudly shouting "Rumsfeld '08!")
[ Post Reply | Private Reply | To 12 | View Replies]

To: neverdem

If there are good drugs out there that will cure or help; they should be available and affordable to the public.

14 posted on 07/13/2008 12:16:22 PM PDT by freekitty (Give me back my conservative vote.)
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794 is powered by software copyright 2000-2008 John Robinson